Logo DHU white

QP-Prostate: Your solution for prostate segmentation and lesion detection based on AI

Keywords: Cancer, Data Analysis, Diagnostics, Imaging, Prediction
Owner
Quibim
Contact
Quibim’s products include quality control of imaging data input, quality standardization, automatic analysis, PACS integration, quantitative information, and output in DICOM standards. We are building an outstanding portfolio of tools for clinical use, including regulatory cleared medical devices to extract objective and accurate information automatically. We partner with top-tier biopharma companies and healthcare institutions to extract the latest insights into cancer and other diseases using medical imaging that can lead to prognostic or predictive models that connect research with personalized care.
Type
Digital solution and service (e.g. application/digital health portal/platform/AI based system/etc.)
Short description
QP-Prostate is an AI-powered solution designed to streamline radiologists’ workflows. By automatically evaluating compliance against PIRADSv2.1 guidelines, segmenting the prostate gland, and identifying suspicious lesions, QP-Prostate empowers radiologists to deliver quicker and more accurate assessments, ultimately enhancing patient care.  These are some of QP-Prostate capabilities: – QP-Prostate automatically highlights regions of the prostate suspicious for clinically significant prostate cancer (csPCa). QP-Prostate provides a High (orange) and Moderate (yellow) risk level, according to the risk of csPCa calculated by the software. Our solution detects suspicious lesions in both the Peripheral and Transitional+Central zones. – QP-Prostate’s AI algorithm automatically identifies the prostate anatomy and segments the full prostate gland, as well as the seminal vesicles, to assist in PSA density calculations. The results can be directly exported for fusion biopsy procedures. – QP-Prostate performs automated difussion (ADC map, synthesized b-1400s/mm2 ) and perfusion analysis to extract clinically meaningful quantitative information from the MRI study. – All analysis outputs are directly sent back to the hospital PACS for their visualization without disrupting radiology workflows. QP-Prostate creates structured reports including quantitative information following PI-RADSv2.1 guidelines. The solution automates prostate gland volume calculation powered by AI, and identifies quantitative imaging biomarkers, ensuring precise measurements for diagnosis.
Maturity
The practice/case/tool is “on the market” and integrated in routine use. There is proven market impact in terms of job creation/spin-off creation or other company growth
Countries
Denmark
Finland
France
Germany
Italy
Norway
Portugal
Spain
Sweden
Switzerland
United Kingdom (please specify)
Geographical scope
International
Language(s)
English
Comment
n/a
Submitted in other database or repository of digital health resources that is publicly available
n/a

Additional information

Relations
to clinicians / care practitioners
Clinical decision support
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)
Care pathway tracking and adherence
Clinical team care planning and collaboration tools (e.g. digital shared care plan)
Primary target patient group (age)
Adults (25-64), Older adults (65+)
Addressed prevention area(s)
Health screenings
Use case and care pathway positioning
Treatment, Disease monitoring, treatment compliance, self-management, Early detection and early diagnosis, precision diagnosis, Prevention and wellness